- Home
- ACT vs MIR Comparison
ACT vs MIR Comparison
Compare ACT & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACT
- MIR
- Stock Information
- Founded
- ACT 1981
- MIR 2005
- Country
- ACT United States
- MIR United States
- Employees
- ACT N/A
- MIR N/A
- Industry
- ACT Specialty Insurers
- MIR Industrial Machinery/Components
- Sector
- ACT Finance
- MIR Technology
- Exchange
- ACT Nasdaq
- MIR Nasdaq
- Market Cap
- ACT 5.1B
- MIR 5.0B
- IPO Year
- ACT 2021
- MIR N/A
- Fundamental
- Price
- ACT $37.80
- MIR $20.71
- Analyst Decision
- ACT Buy
- MIR Strong Buy
- Analyst Count
- ACT 4
- MIR 4
- Target Price
- ACT $37.75
- MIR $18.75
- AVG Volume (30 Days)
- ACT 513.6K
- MIR 3.8M
- Earning Date
- ACT 07-30-2025
- MIR 07-31-2025
- Dividend Yield
- ACT 2.22%
- MIR N/A
- EPS Growth
- ACT 9.98
- MIR N/A
- EPS
- ACT 4.44
- MIR N/A
- Revenue
- ACT $1,216,974,000.00
- MIR $870,200,000.00
- Revenue This Year
- ACT $4.51
- MIR $6.45
- Revenue Next Year
- ACT $4.46
- MIR $7.51
- P/E Ratio
- ACT $8.51
- MIR N/A
- Revenue Growth
- ACT 4.52
- MIR 7.25
- 52 Week Low
- ACT $29.99
- MIR $9.11
- 52 Week High
- ACT $37.97
- MIR $22.21
- Technical
- Relative Strength Index (RSI)
- ACT 65.06
- MIR 57.76
- Support Level
- ACT $34.77
- MIR $20.21
- Resistance Level
- ACT $37.95
- MIR $22.21
- Average True Range (ATR)
- ACT 0.71
- MIR 0.73
- MACD
- ACT 0.18
- MIR -0.12
- Stochastic Oscillator
- ACT 94.69
- MIR 47.55
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.